Benchmark Upgrades Regeneron Pharma (REGN) to Buy
Tweet Send to a Friend
Benchmark analyst Aydin Huseynov upgraded Regeneron Pharma (NASDAQ: REGN) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
